1. Home
  2. NTWK vs BRNS Comparison

NTWK vs BRNS Comparison

Compare NTWK & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTWK
  • BRNS
  • Stock Information
  • Founded
  • NTWK 1997
  • BRNS 2016
  • Country
  • NTWK United States
  • BRNS United Kingdom
  • Employees
  • NTWK N/A
  • BRNS N/A
  • Industry
  • NTWK Computer Software: Prepackaged Software
  • BRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTWK Technology
  • BRNS Health Care
  • Exchange
  • NTWK Nasdaq
  • BRNS Nasdaq
  • Market Cap
  • NTWK 56.1M
  • BRNS 55.9M
  • IPO Year
  • NTWK 1998
  • BRNS 2021
  • Fundamental
  • Price
  • NTWK $4.40
  • BRNS $1.26
  • Analyst Decision
  • NTWK
  • BRNS Strong Buy
  • Analyst Count
  • NTWK 0
  • BRNS 1
  • Target Price
  • NTWK N/A
  • BRNS $3.00
  • AVG Volume (30 Days)
  • NTWK 93.1K
  • BRNS 115.5K
  • Earning Date
  • NTWK 11-12-2025
  • BRNS 11-06-2025
  • Dividend Yield
  • NTWK N/A
  • BRNS N/A
  • EPS Growth
  • NTWK 316.67
  • BRNS N/A
  • EPS
  • NTWK 0.25
  • BRNS N/A
  • Revenue
  • NTWK $66,088,229.00
  • BRNS $14,969,000.00
  • Revenue This Year
  • NTWK N/A
  • BRNS N/A
  • Revenue Next Year
  • NTWK N/A
  • BRNS N/A
  • P/E Ratio
  • NTWK $17.64
  • BRNS N/A
  • Revenue Growth
  • NTWK 7.65
  • BRNS 1766.46
  • 52 Week Low
  • NTWK $2.14
  • BRNS $0.64
  • 52 Week High
  • NTWK $5.75
  • BRNS $2.92
  • Technical
  • Relative Strength Index (RSI)
  • NTWK 46.50
  • BRNS 45.50
  • Support Level
  • NTWK $4.30
  • BRNS $1.20
  • Resistance Level
  • NTWK $4.69
  • BRNS $1.34
  • Average True Range (ATR)
  • NTWK 0.18
  • BRNS 0.11
  • MACD
  • NTWK -0.03
  • BRNS -0.02
  • Stochastic Oscillator
  • NTWK 17.33
  • BRNS 19.67

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Share on Social Networks: